Immunogenicity and Reactogenicity of a Meningococcal B Outer Membrane Vesicle Vaccine Given in a 0,6,12 Month Schedule to Health UK Adults

NCT00197795 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER_GOV

Sponsor class

Conditions

Neisseria Meningitidis

Interventions

BIOLOGICAL: Meningococcal outer membrane vesicle vaccine "MenBVac"

Sponsor

Public Health England